Remarkably, at both pre-symptomatic and end-stage phases of the disease, we observed a strong increase of mTOR levels in SOD1-G93A animals that parallels the increased levels reported for the master regulator of inflammation NF-κB in ALS models [55,56]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.